Research, 2026
Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Han T., Chen L., Liu N. et al.

ACR Open Rheumatology, 2026
Macrophage Activation Syndrome–Associated Proteins and Enhanced Interferon‐γ Responsiveness in the Plasma Proteome of Patients With Multisystem Inflammatory Syndrome in Children in a Pretreatment Replication Single‐Center Cohort

McCuaig S., Toland C., Konvinse K. et al.

Mediators of Inflammation, 2026
Convergent Multistage Evidence Implicates the CCR2–Artemin Immune–Inflammation Axis in Acute Myeloid Leukemia

Jin Y., Lu H., Yu X. et al.

Mediators of Inflammation, 2026
Identification of Treatment Targets in Allergic Conjunctivitis Through Proteome‐Scale Mendelian Randomization Analysis

Li H., Zhang Y., Shang Y. et al.

Journal of Neurosurgery: Pediatrics, 2026
Cell division cycle 42 binding protein beta as a plasma-based biomarker for cerebral cavernous malformations

Hattar Y., Sesen J., Martinez T. et al.

iScience, 2026
Persistent viral control status is associated with enhanced innate immune responses in people with HIV-1

C. dos Santos J., Groenendijk A., Ruijten S. et al.

International Journal of Biological Macromolecules, 2026
A role of FURIN in promoting TGF-β signaling activation in MAFLD: Evidence from UK Biobank proteomic cohort

Wang H., Li X., Xu X. et al.

Journal of Translational Medicine, 2026
Machine learning-based clinical prediction model and multi-omics integration for assessing pancreatic cancer risk in new-onset diabetes

Yang J., Cao B., Yuemaierabola A. et al.

Journal for ImmunoTherapy of Cancer, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

O’Reilly E., Cabanski C., Lyman J. et al.

Diabetologia, 2026
Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia

Mustafajev I., Hendriksz M., Stienstra R. et al.

Blood Immunology & Cellular Therapy, 2026
Identification of a plasma immune marker panel for early detection of acute graft-versus-host disease in children

Klein Lebbink W., de Koning C., Kunstek H. et al.

Reviews in Cardiovascular Medicine, 2026
Olink Proteomics in Heart Failure: A Comprehensive Review of Applications From Biomarker Discovery to Pathophysiological Insights and Clinical Implementation

Zheng Z., Gong Z., Gu J.

eJHaem, 2026
Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP‐4 as Diagnostic and Predictive Biomarkers

Hedberg G., Chen Q., Lakshmikanth T. et al.

GeroScience, 2026
Liver-specific phenotypic aging, behavior and genetic risks, and long-term liver-related outcomes

Wu T., Guo C., Yuan H. et al.

Nature Medicine, 2026
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

Duttagupta S., Messaoudene M., Hunter S. et al.

Preventive Medicine Reports, 2026
Matrix metalloproteinases and risk of cardiovascular mortality and morbidity in the United Kingdom: A prospective cohort study with machine learning analysis

Huang J., Jiang H., Lu Y. et al.

RMD Open, 2026
Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression

Cuesta-López L., Arias-de la Rosa I., Pérez-Sánchez C. et al.

Multiple Sclerosis Journal – Experimental, Translational and Clinical, 2026
Apolipoprotein E4 and its later-life health effects on the multiple sclerosis population

Zeldich D., Cheng C., Guan Y. et al.

Diabetology & Metabolic Syndrome, 2026
The role of hepatocyte growth factor in the relationship between body fat distribution and plasma markers of glucose metabolism: a cross-sectional study

Zakic K., Freuer D., Linseisen J. et al.

Nature Communications, 2026
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank

Rioux B., McGlasson S., Forbes D. et al.